Prelude Therapeutics (PRLD)
0.66
-0.00 (-0.71%)
At close: Apr 10, 2025, 12:49 PM
13F Institute Ownership
Total Institutes of 61 in Prelude Therapeutics reduced their positions with a decrease of 10 investors compared to the previous quarter. A reduction of 3.59M shares, as total invested capital declined by $32.99M with ownership percentage dropping from 47.13% to 42.40%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 14.38% | 10.91M | +0.00% | 13.91M | 0.29% |
| Baker Bros. Advisors LP | 13.35% | 10.12M | +0.00% | 12.91M | 0.14% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.